Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Arch Pharm Res ; 43(6): 646-654, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32533502

RESUMEN

The purpose of this study was to investigate the protective effects of fucoidan on Lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. The mice were divided into the control, LPS, and LPS + fucoidan (20, 40, or 80 mg/kg) groups. LPS was given by intracheal instillation and fucoidan was given 1 h before LPS treatment. Myeloperoxidase (MPO) activity, malondialdehyde (MDA), superoxide dismutase (SOD), reactive oxygen species (ROS), glutathione (GSH) contents, and inflammatory cytokine production were detected. The results showed that LPS-induced TNF-α, IL-1ß, and IL-6 production, lung wet/dry (W/D) ratio, ROS, MDA content, and MPO activity were suppressed by fucoidan. The levels of SOD and GSH were increased by fucoidan. Meanwhile, LPS-induced nuclear factor kappa-B (NF-κB) activation was dose-dependently attenuated by fucoidan. Furthermore, fucoidan increased the expression of nuclear factor erythroid-2 related factor 2 (Nrf2), Glycogen synthase kinase3ß (GSK-3ß), and heme oxygenase (HO-1). In vitro, the results demonstrated that fucoidan or GSK-3ß inhibitor significantly inhibited LPS-induced TNF-α production in A549 cells. And the inhibition of fucoidan on TNF-α production was blocked by Nrf2 siRNA. This study showed fucoidan protected mice against LPS-induced ALI through inhibiting inflammatory and oxidative responses via regulating GSK-3ß-Nrf2 signaling pathway.


Asunto(s)
Lesión Pulmonar Aguda/tratamiento farmacológico , Lipopolisacáridos/antagonistas & inhibidores , Polisacáridos/farmacología , Transducción de Señal/efectos de los fármacos , Células A549 , Lesión Pulmonar Aguda/inducido químicamente , Lesión Pulmonar Aguda/metabolismo , Animales , Relación Dosis-Respuesta a Droga , Glucógeno Sintasa Quinasa 3 beta/antagonistas & inhibidores , Glucógeno Sintasa Quinasa 3 beta/biosíntesis , Humanos , Intubación Intratraqueal , Lipopolisacáridos/farmacología , Masculino , Ratones , Ratones Endogámicos BALB C , Factor 2 Relacionado con NF-E2/biosíntesis , Polisacáridos/administración & dosificación
2.
Asian J Androl ; 22(5): 472-480, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31696835

RESUMEN

Epididymitis can be caused by infectious and noninfectious etiological factors. While microbial infections are responsible for infectious epididymitis, the etiological factors contributing to noninfectious epididymitis remain to be defined. The present study demonstrated that damaged male germ cells (DMGCs) induce epididymitis in mice. Intraperitoneal injection of the alkylating agent busulfan damaged murine male germ cells. Epididymitis was observed in mice 4 weeks after the injection of busulfan and was characterized by massive macrophage infiltration. Epididymitis was coincident with an accumulation of DMGCs in the epididymis. In contrast, busulfan injection into mice lacking male germ cells did not induce epididymitis. DMGCs induced innate immune responses in epididymal epithelial cells (EECs), thereby upregulating the pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1ß (IL-1ß), as well as the chemokines such as monocyte chemotactic protein-1 (MCP-1), monocyte chemotactic protein-5 (MCP-5), and chemokine ligand-10 (CXCL10). These results suggest that male germ cell damage may induce noninfectious epididymitis through the induction of innate immune responses in EECs. These findings provide novel insights into the mechanisms underlying noninfectious epididymitis, which might aid in the diagnosis and treatment of the disease.


Asunto(s)
Citocinas/metabolismo , Epididimitis/inmunología , Epididimitis/patología , Células Germinativas/inmunología , Células Germinativas/metabolismo , Animales , Busulfano , Movimiento Celular , Quimiocina CCL2/metabolismo , Quimiocina CXCL10/metabolismo , Células Germinativas/patología , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Proteínas Quimioatrayentes de Monocitos/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo
3.
Arch Med Res ; 50(6): 384-392, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31678897

RESUMEN

BACKGROUND: T helper 2 (Th2) lymphocytes and associated interleukin (IL) 4 and IL-13 play crucial roles in asthma pathogenesis. In this study, we explored an adeno-associated virus 5 (AAV5) based gene therapy by delivering truncated IL-4 protein to antagonize IL-4 receptor α chain and interrupt asthmatic signal pathway. RESULTS: A recombinant adeno-associated virus 5 (AAV5) vector harboring a truncated mouse IL-4 gene (AAV5-mIL-4ΔC22) was prepared. Western blotting showed that the IL-4 mutant protein lacking the C-terminal 22 amino acids was expressed well in AAV5-mIL-4ΔC22 infected 16HBE and BEAS-2B cells. AAV5-drivn green fluorescent protein (AAV5-GFP) served as a control. The biodistribution of vector DNA after AAV5 vector aerosol inhalation was examined by PCR and the result showed that foreign DNA was detectable in the lungs but not in other organs including gonads. The aerosol inhalation-mediated delivery of AAV5-expressed antagonistic IL-4 mutant protein improved the lung function of ovalbumin-induced asthma mice. CONCLUSIONS: The inhalation of aerosolized AAV5-mIL-4ΔC22 significantly improved the lung function and modulated the immune cell infiltration and associated cytokine expression in the bronchoalveolar lavage fluid (BALF) of ovalbumin-induced asthma mice.


Asunto(s)
Asma/terapia , Terapia Genética/métodos , Subunidad alfa del Receptor de Interleucina-4/antagonistas & inhibidores , Interleucina-4/genética , Administración por Inhalación , Animales , Asma/inducido químicamente , Líquido del Lavado Bronquioalveolar/química , Citocinas/metabolismo , Dependovirus , Modelos Animales de Enfermedad , Femenino , Interleucina-4/inmunología , Pulmón/patología , Ratones , Ratones Endogámicos BALB C , Ovalbúmina/toxicidad , Parvovirinae/genética , Distribución Tisular
4.
Can J Physiol Pharmacol ; 97(5): 345-351, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-29894643

RESUMEN

We aimed to investigate whether the cardioprotection of sevoflurane against ischemia-reperfusion (IR) injury is via inhibiting endoplasmic reticulum stress. The rat in vivo model of myocardial IR injury was induced by ligation of the left anterior descending coronary artery. Sevoflurane significantly ameliorated the reduced cardiac function, increased infarct size, and elevated troponin I level and lactate dehydrogenase activity in plasma induced by IR injury. Sevoflurane suppressed the IR-induced myocardial apoptosis. The increased protein levels of glucose-regulated protein 78 and C/EBP homologous protein (CHOP) after myocardial IR were significantly reduced by sevoflurane. The protein levels of phosphorylated protein kinase RNA-like endoplasmic reticulum kinase (PERK), phosphorylated eukaryotic initiation factor 2 (eIF2α), and activating transcription factor 4 (ATF4) were significantly increased in rats with IR and attenuated by sevoflurane treatment. The phosphorylation of Akt was further activated by sevoflurane. The cardioprotection of sevoflurane could be blocked by wortmannin, a PI3K/Akt inhibitor. Our results suggest that the cardioprotection of sevoflurane against IR injury might be mediated by suppressing PERK/eIF2a/ATF4/CHOP signaling via activating the Akt pathway, which helps in understanding the novel mechanism of the cardioprotection of sevoflurane.


Asunto(s)
Cardiotónicos/farmacología , Estrés del Retículo Endoplásmico/efectos de los fármacos , Daño por Reperfusión Miocárdica/patología , Daño por Reperfusión Miocárdica/prevención & control , Sevoflurano/farmacología , Factor de Transcripción Activador 4/metabolismo , Animales , Apoptosis/efectos de los fármacos , Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/patología , Factor 2 Eucariótico de Iniciación/metabolismo , Corazón/efectos de los fármacos , Corazón/fisiopatología , Masculino , Daño por Reperfusión Miocárdica/metabolismo , Daño por Reperfusión Miocárdica/fisiopatología , Miocardio/metabolismo , Miocardio/patología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacos , eIF-2 Quinasa/metabolismo
5.
J Biomed Nanotechnol ; 12(11): 2001-14, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29364612

RESUMEN

Urinary crystals in normal and kidney stone patients often differ in crystal sizes and surface structures, but the effects of different crystal properties on renal tubular epithelial cells remain unclear. This study aimed to compare the cytotoxicity of micron/nano-calcium oxalate monohydrate (COM) crystals with sizes of 50 nm, 200 nm, 1 µm, 3 µm, and 10 µm to African green monkey renal epithelial (Vero) cells, to reveal the effect of crystal size and surface structure on cell injury, and to investigate the pathological mechanism of calcium oxalate kidney stones. Cell viability, cellular biochemical parameters, and internalized crystal amount in Vero cells were closely associated with the size of COM crystals. At the same concentration (200 µg/mL), COM-1 µm induced the most serious injury to Vero cells and caused the most significant change to cellular biochemical parameters, which were related to the specific porous structure and highest internalized amount in Vero cells. By contrast, COM-50 nm and COM-200 nm crystals lost their small size effect because of serious aggregation and weakened their toxicity to cells. COM-3 µm and COM-10 µm crystals were too large for cells to completely internalize; these crystals also exhibited a low specific surface area and thus weakened their toxicity. The excessive expression of intracellular ROS and reduction of the free-radical scavenger SOD were the main reasons for cell injury and eventually caused necrotic cell death. Crystal size, surface structure, aggregation, and internalization amount were closely related to the cytotoxicity of COM crystals.


Asunto(s)
Oxalato de Calcio/química , Oxalato de Calcio/toxicidad , Supervivencia Celular/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Animales , Chlorocebus aethiops , Células Epiteliales/citología , Riñón/citología , Cálculos Renales , Modelos Biológicos , Tamaño de la Partícula , Células Vero
6.
Mater Sci Eng C Mater Biol Appl ; 57: 147-56, 2015 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-26354249

RESUMEN

Calcium oxalate crystals in urine often differ in size and crystal phase between healthy humans and patients with kidney stones. In this work, calcium oxalate monohydrate (COM) and dihydrate (COD) with sizes of about 50 nm, 100 nm, 1 µm, 3 µm, and 10 µm were prepared by varying reactant concentration, reaction temperature, solvent, mixing manner, and stirring speed. These crystals mainly had a smooth surface and no obvious pore structure, except COM-1 µm. In cell culture medium, the zeta potential of crystals became increasingly negative with increasing size, and the absolute value of zeta potential of COD was greater than the same-sized COM. Results of cell viability and PI staining assays showed that the order of injury degree in African green monkey renal epithelial (Vero) cells caused by different sizes of COD was COD-50 nm>COD-100 nm>COD-1 µm>COD-3 µm>COD-10 µm, and that of different sizes of COM was COM-1 µm>COM-50~COM-100 nm>COM-3 µm>COM-10 µm. COM-1 µm presented the highest cytotoxicity in Vero cells, which was associated with its rougher surface, larger specific surface area (SBET), and larger pore volume. Overall, these findings indicated that the physical properties of crystals play an important role in their cytotoxicity.


Asunto(s)
Oxalato de Calcio/química , Oxalato de Calcio/toxicidad , Supervivencia Celular/efectos de los fármacos , Animales , Chlorocebus aethiops , Relación Dosis-Respuesta a Droga , Ensayo de Materiales , Tamaño de la Partícula , Células Vero
7.
World J Pediatr ; 10(2): 126-32, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24801232

RESUMEN

BACKGROUND: We determined the clinical and molecular genetic characteristics of 8 Chinese patients with Ullrich congenital muscular dystrophy (UCMD). METHODS: Clinical data of probands were collected and muscle biopsies of patients were analyzed. Exons of COL6A1, COL6A2 and COL6A3 were analyzed by direct sequencing. Mutations in COL6A1, COL6A2 and COL6A3 were identified in 8 patients. RESULTS: Among these mutations, 5 were novel [three in the triple helical domain (THD) and 2 in the second C-terminal (C2) domain]. We also identified five known missense or in-frame deletion mutations in THD and C domains. Immunohistochemical studies on muscle biopsies from patients showed reduced level of collagen VI at the muscle basement membrane and mis-localization of the protein in interstitial and perivascular regions. CONCLUSIONS: The novel mutations we identified underscore the importance of THD and C2 domains in the assembly and function of collagen VI, thereby providing useful information for the genetic counseling of UCMD patients.


Asunto(s)
Colágeno Tipo VI/genética , Distrofias Musculares/genética , Mutación , Esclerosis/genética , Adolescente , Alelos , Sustitución de Aminoácidos , Biopsia , Niño , Preescolar , China , Codón , Femenino , Mutación del Sistema de Lectura , Humanos , Inmunohistoquímica , Masculino , Distrofias Musculares/diagnóstico , Mutación Missense , Polimorfismo de Nucleótido Simple , Esclerosis/diagnóstico , Eliminación de Secuencia
8.
Cancer Res ; 72(8): 2089-99, 2012 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-22496463

RESUMEN

Although cancer tends to affect the elderly, most preclinical studies are carried out in young subjects. In this study, we developed a melanoma-specific cancer immunotherapy that shows efficacy in aged but not young hosts by mitigating age-specific tumor-associated immune dysfunction. Both young and aged CD4(+)CD25(hi) regulatory T cells (Treg) exhibited equivalent in vitro T-cell suppression and tumor-associated augmentation in numbers. However, denileukin diftitox (DT)-mediated Treg depletion improved tumor-specific immunity and was clinically effective only in young mice. DT-mediated Treg depletion significantly increased myeloid-derived suppressor cell (MDSC) numbers in aged but not young mice, and MDSC depletion improved tumor-specific immunity and reduced tumor growth in aged mice. Combining Treg depletion with anti-Gr-1 antibody was immunologically and clinically more efficacious than anti-Gr-1 antibody alone in aged B16-bearing mice, similar to Treg depletion alone in young mice. In contrast, DT increased MDSCs in young and aged mice following MC-38 tumor challenge, although effects were greater in aged mice. Anti-Gr-1 boosted DT effects in young but not aged mice. Aged antitumor immune effector cells are therefore competent to combat tumor when underlying tumor-associated immune dysfunction is appropriately mitigated, but this dysfunction varies with tumor, thus also varying responses to immunotherapy. By tailoring immunotherapy to account for age-related tumor-associated immune dysfunctions, cancer immunotherapy for aged patients with specific tumors can be remarkably improved.


Asunto(s)
Envejecimiento/inmunología , Inmunoterapia/métodos , Neoplasias Experimentales/inmunología , Neoplasias Experimentales/terapia , Receptores de Superficie Celular/antagonistas & inhibidores , Animales , Anticuerpos Monoclonales/uso terapéutico , Antineoplásicos/uso terapéutico , Toxina Diftérica/uso terapéutico , Modelos Animales de Enfermedad , Citometría de Flujo , Interleucina-2/uso terapéutico , Depleción Linfocítica/métodos , Ratones , Ratones Endogámicos C57BL , Proteínas Recombinantes de Fusión/uso terapéutico , Linfocitos T Reguladores/inmunología
9.
Anesthesiology ; 104(3): 482-7, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16508395

RESUMEN

BACKGROUND: As in inhaled isoflurane anesthesia, when isoflurane lipid emulsion (ILE; 8%, vol/vol) is intravenously administered, the primary elimination route is through the lungs. This study was designed to determine the minimum alveolar concentration (MAC) and the time course of washout of isoflurane for intravenously infused ILE by monitoring end-tidal isoflurane concentration. METHODS: Twelve healthy adult mongrel dogs were assigned randomly to an intravenous anesthesia group with 8% ILE or to an inhalation anesthesia group with isoflurane vapor. An up-and-down method and stimulation of tail clamping were used to determine MAC of 8% ILE by intravenous injection in the intravenous anesthesia group and MAC by the inhaled approach in the inhalation anesthesia group, respectively. Isoflurane concentration and partial pressure in end-tidal gas, femoral arterial blood, and jugular venous blood were measured simultaneously just before each tail clamping and during washout. RESULTS: The induction time in the intravenous anesthesia group (105 +/- 24 s) was shorter than that in the inhalation anesthesia group (378 +/- 102 s; P < 0.01). MAC of 8% ILE by intravenous injection (1.12 +/- 0.18%) was significantly less than MAC by the inhaled approach (1.38 +/- 0.16%; P < 0.05). No significant difference was found between the two groups in the time course of washout of isoflurane. CONCLUSION: The MAC of intravenous anesthesia with 8% ILE was less than that of inhalation anesthesia with isoflurane vapor in dogs.


Asunto(s)
Anestésicos por Inhalación/administración & dosificación , Emulsiones Grasas Intravenosas/administración & dosificación , Isoflurano/administración & dosificación , Alveolos Pulmonares/metabolismo , Administración por Inhalación , Animales , Perros , Isoflurano/farmacocinética , Isoflurano/farmacología
10.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 36(1): 124-6, 2005 Jan.
Artículo en Chino | MEDLINE | ID: mdl-15702800

RESUMEN

OBJECTIVE: To assess the sensitivity and accuracy of a novel transesophageal approach to monitoring the descending aortic oximetry (SeO2). METHODS: Nine dogs were involved in the experimental study. After the induction of anaesthesia, the carrier of the oximetry probe (Nellcor-D20, USA) was inserted into the lower segment of esophagus to monitor SeO2, and the probe was "locked" in position of post-descending aorta after the opening of thoracic cavity. Another probe was pasted on the surface of lingual mucous membrane. The readings and figures of SeO2 and surface of lingual mucosa oximetry (SmO2) were observed continuously and recorded simultaneously. Vital signs were monitored with pulse oxygen saturation (SpO2), invasive blood pressure by femoral artery, HR, EKG, PetCO2, T, FiO2. The SaO2 of blood gas analysis by femoral artery was used as the "gold standard" to calculated the relative and absolute deviations of SeO2 and SmO2. The changes of SeO2 and SaO2 were compared in case of acute hypoxia when values of SmO2 dropped to 90%, 80%, 70%, 60% and the patient was re-ventilated with 100% oxygen. RESULTS: (1) SeO2, SmO2 and SaO2 were 100% when the patients were ventilated with 100% oxygen. During hypoxia, the descent of SeO2 from 100% to 90% was (91.03+/-20.23) s (P<0.001) earlier than that of SmO2. And after re-supply of pure oxygen, the ascent of SeO2 was (25.9+/-6.0) s (P<0.05) earlier than that of SmO2. (2) SaO2 was well related with SeO2 and SmO2 (R2: 0.9884 and 0.9296) respectively. The relative and absolute deviations of SeO2 were 1.6% and 1.3%, while those of SmO2 were 7.6% and 6.1% from arterial blood samples SaO2. (3) There were no significant differences in MAP, HR, ECG, PetCO2 and T. CONCLUSION: This study showed that SeO2 monitoring is sensitive. It could accurately reflect the arterial oxygen saturation not only in normal condition but also during hypoxia and the re-ventilation with 100% oxygen. SeO2 responds faster and is closer to SaO2, compared with SmO2 measurements. This may be an alternative method in the cases where the monitoring of peripheral SpO2 is difficult.


Asunto(s)
Análisis de los Gases de la Sangre/métodos , Oximetría/métodos , Oxígeno/sangre , Animales , Análisis de los Gases de la Sangre/instrumentación , Perros , Esófago , Femenino , Masculino , Monitoreo Fisiológico/instrumentación , Oximetría/instrumentación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...